Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Product: | Rivaroxaban Viatris |
| Active Ingredient: | Rivaroxaban 10mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Viatris Limited |
| Manufacturer: | Mylan Laboratories Limited, Aurangabad, India |
| Product: | Rivaroxaban Viatris |
| Active Ingredient: | Rivaroxaban 15mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Viatris Limited |
| Manufacturer: | Mylan Laboratories Limited, Aurangabad, India |
| Product: | Rivaroxaban Viatris |
| Active Ingredient: | Rivaroxaban 20mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Viatris Limited |
| Manufacturer: | Mylan Laboratories Limited, Aurangabad, India |
| Product: | Zonisamide Te Arai |
| Active Ingredient: | Zonisamide 25mg |
| Dosage Form: | Capsule |
| New Zealand Sponsor: | Te Arai BioFarma Limited |
| Manufacturer: | Cohance Lifesciences Limited, Telangana, India |
| Product: | Zonisamide Te Arai |
| Active Ingredient: | Zonisamide 50mg |
| Dosage Form: | Capsule |
| New Zealand Sponsor: | Te Arai BioFarma Limited |
| Manufacturer: | Cohance Lifesciences Limited, Telangana, India |
| Product: | Zonisamide Te Arai |
| Active Ingredient: | Zonisamide 100mg |
| Dosage Form: | Capsule |
| New Zealand Sponsor: | Te Arai BioFarma Limited |
| Manufacturer: | Cohance Lifesciences Limited, Telangana, India |
Dated this 21st day of July 2023.
DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).